Matches in SemOpenAlex for { <https://semopenalex.org/work/W4380029491> ?p ?o ?g. }
Showing items 1 to 58 of
58
with 100 items per page.
- W4380029491 endingPage "1483" @default.
- W4380029491 startingPage "1483" @default.
- W4380029491 abstract "Abstract The purpose of this project was to identify small molecules which reprogram tumor cells into an anticancer phenotype. Far upstream binding protein 1 (FUBP1) has been identified as a master regulator of a panel of genes involved in tumor survival including c-Myc and p21. FUBP1 controls gene expression by binding to specific far upstream element (FUSE) DNA sequences of the promoters of key tumor survival genes to regulate their transcription to provide a pro-tumor phenotype (high c-Myc, low p21). This makes FUBP1 a novel therapeutic target as its inhibition reprograms tumors to an anti-cancer phenotype (low c-Myc, high p21). This report describes the development of novel anthranilic acid derivatives which bind to FUBP1 (as shown by ChIP and gel shift assays) and modulate the mRNA and protein expression (qRT-PCR and Western) of FUSE-controlled genes (e.g., c-Myc and p21). The lead compound UCF699 was shown to reprogram pancreatic ductal adenocarcinoma (PDAC) cells into an anti-cancer phenotype in a dose-dependent manner and inhibit pancreatic cancer cell growth. In summary, the ability of UCF699 to control the expression of multiple FUSE-controlled genes and to reprogram tumor cells into an anti-cancer phenotype provides an exciting new way to treat pancreatic tumors. Citation Format: Alexandra Bunea, Christopher Polera, Aiste Dobrovolskaite, Holly Moots, Otto Phanstiel. Development of FUBP1 inhibitors to reprogram pancreatic cancer cells into an anti-cancer phenotype [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 1483." @default.
- W4380029491 created "2023-06-10" @default.
- W4380029491 creator A5020990687 @default.
- W4380029491 creator A5024296509 @default.
- W4380029491 creator A5046690803 @default.
- W4380029491 creator A5079082784 @default.
- W4380029491 creator A5092124298 @default.
- W4380029491 date "2023-04-04" @default.
- W4380029491 modified "2023-09-25" @default.
- W4380029491 title "Abstract 1483: Development of FUBP1 inhibitors to reprogram pancreatic cancer cells into an anti-cancer phenotype" @default.
- W4380029491 doi "https://doi.org/10.1158/1538-7445.am2023-1483" @default.
- W4380029491 hasPublicationYear "2023" @default.
- W4380029491 type Work @default.
- W4380029491 citedByCount "0" @default.
- W4380029491 crossrefType "journal-article" @default.
- W4380029491 hasAuthorship W4380029491A5020990687 @default.
- W4380029491 hasAuthorship W4380029491A5024296509 @default.
- W4380029491 hasAuthorship W4380029491A5046690803 @default.
- W4380029491 hasAuthorship W4380029491A5079082784 @default.
- W4380029491 hasAuthorship W4380029491A5092124298 @default.
- W4380029491 hasConcept C104317684 @default.
- W4380029491 hasConcept C121608353 @default.
- W4380029491 hasConcept C127716648 @default.
- W4380029491 hasConcept C2779256057 @default.
- W4380029491 hasConcept C2780210213 @default.
- W4380029491 hasConcept C502942594 @default.
- W4380029491 hasConcept C54355233 @default.
- W4380029491 hasConcept C86803240 @default.
- W4380029491 hasConcept C96232424 @default.
- W4380029491 hasConceptScore W4380029491C104317684 @default.
- W4380029491 hasConceptScore W4380029491C121608353 @default.
- W4380029491 hasConceptScore W4380029491C127716648 @default.
- W4380029491 hasConceptScore W4380029491C2779256057 @default.
- W4380029491 hasConceptScore W4380029491C2780210213 @default.
- W4380029491 hasConceptScore W4380029491C502942594 @default.
- W4380029491 hasConceptScore W4380029491C54355233 @default.
- W4380029491 hasConceptScore W4380029491C86803240 @default.
- W4380029491 hasConceptScore W4380029491C96232424 @default.
- W4380029491 hasIssue "7_Supplement" @default.
- W4380029491 hasLocation W43800294911 @default.
- W4380029491 hasOpenAccess W4380029491 @default.
- W4380029491 hasPrimaryLocation W43800294911 @default.
- W4380029491 hasRelatedWork W1906345089 @default.
- W4380029491 hasRelatedWork W2043890160 @default.
- W4380029491 hasRelatedWork W2339808165 @default.
- W4380029491 hasRelatedWork W2344637265 @default.
- W4380029491 hasRelatedWork W2487824964 @default.
- W4380029491 hasRelatedWork W2582912872 @default.
- W4380029491 hasRelatedWork W2764038087 @default.
- W4380029491 hasRelatedWork W2885662959 @default.
- W4380029491 hasRelatedWork W2974647127 @default.
- W4380029491 hasRelatedWork W3013358603 @default.
- W4380029491 hasVolume "83" @default.
- W4380029491 isParatext "false" @default.
- W4380029491 isRetracted "false" @default.
- W4380029491 workType "article" @default.